Tuberculosis reactivation risk in patients treated with tumor necrosis factor alpha inhibitors: a turkish experience with higher mortality and different background diseases.

Kısacık, BünyaminPamuk, ÖmerOnat, Ahmet MesutErer, BurakHatemi, GülenÖzgüler, YeşimKılıç, LeventErtenli, İhsanCan, MeryemDireskeneli, HanerKeser, GökhanÖksel, FahrettinYılmaz, SedatPay, SalihBalkarlı, AyşeÇobankara, VeliÇetin, Gözde YıldırımSayarlıoğlu, MehmetCefle, AyşeYazıcı, AytenAvcı, Ali BerkantTerzioğlu, EnderÖzbek, SüleymanAkar, ServetGül, Ahmet2024-02-052024-02-052014-10Pehlivan, Y. vd. (2014). "Tuberculosis reactivation risk in patients treated with tumor necrosis factor alpha inhibitors: A turkish experience with higher mortality and different background diseases.". Arthritis & Rheumatology, Supplement: 10, Special Issue: SI, Meeting Abstract: 2157, 66, S943-S943.2326-51912326-5205https://hdl.handle.net/11452/39489eninfo:eu-repo/semantics/closedAccessTuberculosis reactivation risk in patients treated with tumor necrosis factor alpha inhibitors: a turkish experience with higher mortality and different background diseases.Article000344384904305S943S94366Rheumatology